spacer
spacer

PDBsum entry 1g0y

Go to PDB code: 
protein Protein-protein interface(s) links
Immune system PDB id
1g0y

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
310 a.a. *
21 a.a. *
* Residue conservation analysis
PDB id:
1g0y
Name: Immune system
Title: Il-1 receptor type 1 complexed with antagonist peptide af10847
Structure: Interleukin-1 receptor, type i. Chain: r. Engineered: yes. Antagonist peptide af10847. Chain: i. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: unidentified baculovirus. Expression_system_taxid: 10469. Expression_system_cell: sf9 cells. Synthetic: yes. Other_details: the peptide was synthesized by solid-phase synthesis.
Biol. unit: Dimer (from PQS)
Resolution:
3.00Å     R-factor:   0.223     R-free:   0.332
Authors: G.P.A.Vigers,D.J.Dripps,C.K.Edwards,B.J.Brandhuber
Key ref:
G.P.Vigers et al. (2000). X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1. J Biol Chem, 275, 36927-36933. PubMed id: 10903327 DOI: 10.1074/jbc.M006071200
Date:
09-Oct-00     Release date:   25-Oct-00    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P14778  (IL1R1_HUMAN) -  Interleukin-1 receptor type 1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
569 a.a.
310 a.a.
Protein chain
No UniProt id for this chain
Struc: 21 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chain R: E.C.3.2.2.6  - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: NAD+ + H2O = ADP-D-ribose + nicotinamide + H+
NAD(+)
+ H2O
= ADP-D-ribose
+ nicotinamide
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1074/jbc.M006071200 J Biol Chem 275:36927-36933 (2000)
PubMed id: 10903327  
 
 
X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1.
G.P.Vigers, D.J.Dripps, C.K.Edwards, B.J.Brandhuber.
 
  ABSTRACT  
 
Interleukin (IL-1)alpha and IL-1beta are important mediators of inflammation. The binding of IL-1 to interleukin-1 receptor (IL-1R) type 1 is the initial step in IL-1 signal transduction and therefore is a tempting target for anti-inflammatory therapeutics. To advance our understanding of IL-1R1 binding interactions, we have determined the structure of the extracellular domains of IL-1R1 bound to a 21-amino acid IL-1 antagonist peptide at 3.0-A resolution. The antagonist peptide binds to the domain 1/2 junction of the receptor, which is a conserved binding site for IL-1beta and IL-1 receptor antagonist (IL-1ra). This co-crystal structure also reveals that considerable flexibility is present in IL-1R1 because the carboxyl-terminal domain of the receptor is rotated almost 170 degrees relative to the first two domains of the receptor compared with the previously solved IL-1R1.ligand structures. The structure shows an unexpected binding mode for the peptide and may contribute to the design of smaller IL-1R antagonists.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Structures of IL-1R1·IL-1 and IL-1R1·IL-1ra. Shown is a comparison of the structures of the IL-1R1·IL-1 complex (left) and the IL-1R1·IL-1ra complex (right). The two structures look very similar, but in the IL-1ra complex, the third domain swings 20° away from the ligand. The receptor is orientated such that the cell membrane, if present, would be at the bottom of the figure. The amino terminus of the receptor is at the top right, and the carboxyl terminus at the bottom. The conserved binding site (Site A) lies between the first and second immunoglobulin domains, whereas the second binding site (Site B), which is utilized by IL-1 , but not by IL-1ra, lies on the face of the third domain. The structures are colored by change in solvent-accessible surface upon ligand binding. The color scheme ranges from dark blue (<20 Å2) to red (>90 Å2).
Figure 2.
Fig. 2. Structure of the IL-1R1· AF10847 complex. Left, the orientation of the first and second domains of IL-1R1 is the same as described in the legend to Fig. 1. The third domain has swung around 168° to touch the first domain, and binding Site B now faces away from the ligand. The peptide forms an -helix through Site A, with two long strands lying along the sides of IL-1R1. IL-1R1 is colored by secondary structure, and AF10847 is magenta. Right, the same complex is shown, viewed from the "top" of the receptor, looking into Site A. This view shows how the tails of the peptide (shown in magenta) wrap around IL-1R1.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2000, 275, 36927-36933) copyright 2000.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21481778 E.Karaca, and A.M.Bonvin (2011).
A multidomain flexible docking approach to deal with large conformational changes in the modeling of biomolecular complexes.
  Structure, 19, 555-565.  
20802483 D.Wang, S.Zhang, L.Li, X.Liu, K.Mei, and X.Wang (2010).
Structural insights into the assembly and activation of IL-1β with its receptors.
  Nat Immunol, 11, 905-911.
PDB code: 3o4o
19836339 A.Lingel, T.M.Weiss, M.Niebuhr, B.Pan, B.A.Appleton, C.Wiesmann, J.F.Bazan, and W.J.Fairbrother (2009).
Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.
  Structure, 17, 1398-1410.
PDB code: 2kll
17380484 S.Somani, C.P.Chng, and C.S.Verma (2007).
Hydration of a hydrophobic cavity and its functional role: a simulation study of human interleukin-1beta.
  Proteins, 67, 868-885.  
14746812 J.A.Langer, E.C.Cutrone, and S.Kotenko (2004).
The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions.
  Cytokine Growth Factor Rev, 15, 33-48.  
11790541 J.E.Sims (2002).
IL-1 and IL-18 receptors, and their extended family.
  Curr Opin Immunol, 14, 117-122.  
11746948 R.L.Rich, and D.G.Myszka (2001).
Survey of the year 2000 commercial optical biosensor literature.
  J Mol Recognit, 14, 273-294.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer